From June 10 to 12, 2022, the 14th China Bioindustry Conference was successfully held in Guangzhou International Bio Island. As an important platform for the global bio pharmaceutical industry to show the latest achievements, talk about cutting-edge innovation, and promote cooperation and exchange, the Conference effectively helped Guangzhou build a bio pharmaceutical highland with global influence. 2022年6月10日到12日，第十四届中国生物产业大会在广州国际生物岛成功举行，本次大会作为全球生物医药产业展示最新成果、共话前沿创新、促进合作交流的重要平台，有效助力广州打造具有全球影响力的生物医药高地。




Professor Wang Jianxun was invited as the keynote speaker to deliver a keynote speech entitled "Establishment of a standardized industrial production system GMP for cells and gene therapy vectors" at the conference, introducing the current situation and prospects of the cell immunotherapy industry, as well as the main service modules and main products of Junhou Biotech: industrial retroviral vectors. Compared with its scientific research level vectors, industrial retroviral vectors have large capacity and low cost, And the release standard is strict, with obvious advantages. Professor Wang Jianxun introduced the establishment of the GMP production system in detail, and emphasized that the top priority of the GMP production system is the cultivation of talents. At the same time, the difference between retroviral vectors, lentiviral vectors and adeno-associated viral vectors for popular science and the advantages of retroviral vectors over other vectors lie in their low cost and high safety. Retroviral vector technology was recognized by the audience with its unique advantages.王建勋教授受邀作为主讲嘉宾，在大会上发表以《细胞和基因治疗载体的规范化标准化工业生产体系GMP的建立》为题的主题演讲，介绍了细胞免疫治疗的行业现状、前景以及君厚生物的主要服务模块及主营产品：工业级逆转录病毒载体，工业级逆转录病毒载体相较其科研级别载体，产能大成本低，且放行标准严格，优势明显。王建勋教授详细的介绍了GMP生产体系的搭建，并强调GMP生产体系的重中之重是对人才的培养，同时为观众科普逆转录病毒载体、慢病毒载体和腺相关病毒载体的区别以及逆转录病毒载体较之其它载体的优势在于其成本较低并且安全性较高，逆转录病毒载体技术以其特有的优势得到在场观众的肯定。